1. Home
  2. ICHR vs MNKD Comparison

ICHR vs MNKD Comparison

Compare ICHR & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$48.43

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.05

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICHR
MNKD
Founded
1999
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2016
2004

Fundamental Metrics

Financial Performance
Metric
ICHR
MNKD
Price
$48.43
$3.05
Analyst Decision
Strong Buy
Buy
Analyst Count
6
6
Target Price
$40.67
$8.75
AVG Volume (30 Days)
1.2M
5.3M
Earning Date
05-06-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
$947,652,000.00
$348,966,000.00
Revenue This Year
$16.08
$24.57
Revenue Next Year
$11.64
$14.12
P/E Ratio
N/A
$163.25
Revenue Growth
11.61
22.23
52 Week Low
$13.15
$2.94
52 Week High
$55.00
$6.51

Technical Indicators

Market Signals
Indicator
ICHR
MNKD
Relative Strength Index (RSI) 63.67 17.38
Support Level $15.70 N/A
Resistance Level N/A $6.08
Average True Range (ATR) 4.08 0.39
MACD -0.32 -0.30
Stochastic Oscillator 55.63 3.37

Price Performance

Historical Comparison
ICHR
MNKD

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: